Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2127639

Cl.OCN(CO)CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL8937711 0.95
Bromide SCHEMBL28573238 0.94
SCHEMBL38348 0.94
SCHEMBL931012 0.94
Ethane SCHEMBL27510381 0.91 ALDH1A1 (0.31)
Fluoride SCHEMBL1813540 0.89
Methane SCHEMBL4071167 0.89
Water SCHEMBL8055195 0.89
SCHEMBL28058931 0.89
Ethane SCHEMBL21355765 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120698793-A Method for producing oxide ceramic particles coated with aminated functional groups 深圳同兴达科技股份有限公司 2025-09-26 CN disclosed
CN-119405819-A Curcumin-loaded engineering cell membrane nano vesicle NVs-CUR and preparation method thereof 新疆医科大学第一附属医院 2025-02-11 CN disclosed
CN-114235769-B Blood cell staining method 深圳市路美康尔医疗科技有限公司 2024-04-12 CN disclosed
US-10948437-B2 Method for analysis using X-ray fluorescence ICAGEN, LLC (US) 2021-03-16 US disclosed
CN-105744983-B Device and method for sustained release of therapeutic agents of low water solubility in solubilizing agents 纳米医学系统公司 2019-12-27 CN disclosed
US-10458933-B2 Method for analysis using X-ray fluorescence ICAGEN, INC. (US) 2019-10-29 US disclosed
WO-2019075711-A1 METHOD FOR ELIMINATING RESIDUE OF REGENERATIVE AGENT 深圳华大智造科技有限公司 2019-04-25 WO disclosed
US-20190011382-A1 METHOD FOR ANALYSIS USING X-RAY FLUORESCENCE ICAGEN, INC. (US) 2019-01-10 US disclosed
US-10082474-B2 Method for analysis using X-ray fluorescence ICAGEN, INC. (US) 2018-09-25 US disclosed
US-20160341678-A1 Method for Analysis Using X-Ray Fluorescence ICAGEN, INC. (US) 2016-11-24 US disclosed
US-20120093286-A1 Method for analysis using x-ray fluorescence ADJACENT ACQUISITION CO., LLC 2012-04-19 US disclosed
WO-2012050620-A1 METHOD FOR ANALYSIS USING X-RAY FLOURESCENCE CALDERA PHARMACEUTICALS, INC. (US) 2012-04-19 WO disclosed
CN-100455599-C Gene recombinant antibody and its fragment KYOWA HAKKO KOGYO KK (JP) 2009-01-28 CN disclosed
CN-1407993-A Gene recombinant antibody and its fragment KYOWA HAKKO KOGYO KK (JP) 2003-04-02 CN disclosed
WO-1994018852-A1 METHOD FOR EXTRACTING SOYBEAM PEROXIDASE FROM SOYBEAN HULLS AND RECOVERING A PRODUCT USEFUL AS A FIBER SUPPLEMENT ENZYMOL INTERNATIONAL, INC. (US) 1994-09-01 WO disclosed
EP-0240914-B1 PEPTIDE DERIVATIVES AND ACTIVITY MEASURING METHOD OF PHYSIOLOGICALLY ACTIVE SUBSTANCES USING THE SAME AS SUBSTRATES WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1992-08-19 EP disclosed
US-5120644-A Reacting enzyme with substrate containing fluorescent substituent WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-09 US disclosed
EP-0104912-A2 Liquid chromatographic column packing material Hitachi Chemical Co., Ltd. (JP) 1984-04-04 EP disclosed
US-4041712-A CATIONIC EMULSION OF PETROLEUM ASPHALT, NONIONIC SURFACTANTS, ELASTOMERS THE FLINTKOTE COMPANY (US) 1977-08-16 US disclosed
US-3979916-A Product and method for reducing water loss through soil by seepage THE FLINTKOTE COMPANY (US) 1976-09-14 US disclosed